Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes
Open Access
- 1 January 2011
- journal article
- Published by OMICS Publishing Group in Journal of Diabetes & Metabolism
- Vol. 02 (04)
- https://doi.org/10.4172/2155-6156.1000126